Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Announcements  for Shilpa Medicare Ltd.

12 Jul
Announcement under Regulation 30 (LODR)-Earnings Call Transcript  
11 Jul
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018  
09 Jul
Shilpa Pharma Lifesciences Limited, Unit 2, Raichur, Karnataka Has Cleared The ANVISA-Brazil GMP Inspection  
08 Jul
Announcement Under ''Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,Allotment Of Equity Shares By Shilpa Biologicals Pvt. Ltd. (SBPL), A Wholly Owned Subsidiary Of Shilpa Medicare Ltd.  
08 Jul
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome  
05 Jul
Analysts / Investors' Call  
04 Jul
Important Milestone For The CDMO Business Of Shilpa Medicare Limited ('SML')  
25 Jun
USFDA Inspection Close-Out Of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacharam, Hyderabad, Telangana.  
04 Jun
Type IV DMF (Drug Master File) Of Recombinant Human Albumin 20%  
29 May
Compliances-Reg.24(A)-Annual Secretarial Compliance  
View announcements for all companies
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com